Hubei Goto Biopharm Co (SZSE:300966) ROCE % : -1.97% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hubei Goto Biopharm Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hubei Goto Biopharm Co's annualized ROCE % for the quarter that ended in Sep. 2024 was -1.97%.

Hubei Goto Biopharm Co ROCE % Historical Data

The historical data trend for Hubei Goto Biopharm Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Goto Biopharm Co ROCE % Chart

Hubei Goto Biopharm Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

18.51

12.41

12.71

4.38

1.98

Hubei Goto Biopharm Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															1.70	0.87	1.20	-1.77	-1.97

Hubei Goto Biopharm Co ROCE % Calculation

Hubei Goto Biopharm Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	32.298	/	( ( (2069.305 - 575.968)	+	(2447.741 - 686.406) )	/ 2 )
	=	32.298	/	( (1493.337	+	1761.335)	/ 2 )
	=	32.298	/	1627.336
	=	1.98 %

Hubei Goto Biopharm Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-38.144	/	( ( (2772.474 - 808.879)	+	(2697.253 - 782.001) )	/ 2 )
	=	-38.144	/	( ( 1963.595	+	1915.252 )	/ 2 )
	=	-38.144	/	1939.4235
	=	-1.97 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Hubei Goto Biopharm Co (SZSE:300966) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hubei Goto Biopharm Co ROCE % Related Terms

Thank you for viewing the detailed overview of Hubei Goto Biopharm Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Goto Biopharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hubei Goto Biopharm Co Ltd (SZSE:300966) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gaokeng Group, Xiaohe Town, Hubei Province, Yicheng, CHN, 441002

Website

http://www.gotopharm.com

Hubei Goto Biopharm Co Ltd is engaged in the research and development, production, and sales of steroidal hormone drug raw materials.

Executives

Li Ming Lei	Directors, executives
Jiang Jian Jun	Supervisors

Hubei Goto Biopharm Co Headlines

No Headlines